Opera Ltd Beats Q2 Expectations, Boosts Full-Year Guidance
Ticker: OPRA · Form: 6-K · Filed: Aug 19, 2025 · CIK: 1737450
| Field | Detail |
|---|---|
| Company | Opera LTD (OPRA) |
| Form Type | 6-K |
| Filed Date | Aug 19, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: earnings, guidance-raise, results
TL;DR
Opera crushed Q2, raising full-year outlook. Buy.
AI Summary
Opera Limited announced on August 19, 2025, that it reported second quarter 2025 results exceeding expectations and raised its full-year guidance. The company filed a Form 6-K report detailing these positive developments.
Why It Matters
This filing indicates strong performance for Opera Limited, suggesting potential for increased revenue and profitability, which could positively impact its stock price.
Risk Assessment
Risk Level: low — The filing is a routine earnings report and guidance update, with no immediate negative news.
Key Players & Entities
- Opera Limited (company) — Registrant
- August 19, 2025 (date) — Filing and press release date
- James Yahui Zhou (person) — Chairman of the Board and Chief Executive Officer
- 001-38588 (other) — Commission File Number
FAQ
What specific financial metrics exceeded expectations in Q2 2025?
The filing does not provide specific Q2 2025 financial metrics in the provided text, only that results were 'ahead of expectations'.
What is the updated full-year guidance for Opera Limited?
The filing states that full-year guidance was raised, but the specific details of the updated guidance are not included in this excerpt.
What is the primary exhibit attached to this 6-K filing?
Exhibit 99.1 is a press release dated August 19, 2025, titled 'Opera Reports Second Quarter 2025 Results Ahead of Expectations, Raises Full-Year Guidance'.
Who signed this Form 6-K report on behalf of Opera Limited?
James Yahui Zhou, Chairman of the Board and Chief Executive Officer, signed the report.
What is Opera Limited's principal executive office address?
The principal executive office is located at Vitaminveien 4, 0485 Oslo, Norway.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 13.2 · Accepted 2025-08-19 07:01:25
Filing Documents
- opra_6-k_2025q2_earnings.htm (6-K) — 17KB
- opra-ex99_1.htm (EX-99.1) — 1229KB
- img39877525_0.jpg (GRAPHIC) — 363KB
- 0001737450-25-000003.txt ( ) — 1747KB
From the Filing
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-38588 OPERA LIMITED Vitaminveien 4, 0485 Oslo, Norway (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated August 19, 2025, titled “Opera Reports Second Quarter 2025 Results Ahead of Expectations, Raises Full-Year Guidance” SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Opera Limited Date: August 19, 2025 By: /s/ James Yahui Zhou Name: James Yahui Zhou Title: Chairman of the Board and Chief Executive Officer